Free eBook: Vaccine Contract Research A look at the next biggest markets for CROs – Who’s after China and India?

Here is the much-anticipated second eBook in the Vaccine Nation series. Please tell us what you think in the comment box below! Over the past 10 years, CROs have raised their levels of services and become more sophisticated operations. They’re becoming the place where expertise resides. In fact, 2010 marked the first time employment at CROs exceeded those at major …

CRO Vaccine expertise & emerging market access: what’s the value for companies entering into the clinical research arena?

Emerging Markets are key to vaccine development, CRO partners understanding of the challenges involved and knowledge of how to overcome them is key to the success of any trial. Join us on the 11th April to hear from Mark Wood, Associate Director for Proposals & Business Intelligence at Encorium to understand why the range of experience from developing Clinical Developments …

Climate change in vaccine trials: Moving from a one-size-fits-all to a custom fit in operational delivery

Dr Vigdorth has 30 years of drug development research experience in the clinical setting and pharmaceutical and CRO industries. She has led clinical development programs across a range of therapeutic indications with extensive experience in antibiotic, antiviral, vaccine, and antifungal agents.   Dr Vigdorth's experience has developed from multiple perspectives including working in the clinical investigative site setting, multi- national …